Tapering towards DMARD-free remission in established rheumatoid arthritis: 2-year results of the TARA trial

OBJECTIVES: To evaluate the 2-year clinical effectiveness of two gradual tapering strategies. The first strategy consisted of tapering the conventional synthetic disease-modifying antirheumatic drugs (csDMARDs) first (i.e., methotrexate in ~90%), followed by the tumour necrosis factor inhibitor (TNF...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Ann Rheum Dis
Prif Awduron: van Mulligen, Elise, Weel, Angelique E, Hazes, J M, van der Helm-van Mil, Annette, de Jong, Pascal Hendrik Pieter
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: BMJ Publishing Group 2020
Pynciau:
Rheumatoid Arthritis
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC7456559/
https://ncbi.nlm.nih.gov/pubmed/32482645
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/annrheumdis-2020-217485
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg